Skip to Main Content
Kallyope logo
Close Menu
    • About Us
    • Pipeline
    • Platform
    • Partnering
    • News
    • Careers
    Contact Us

TRPM8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine as presented at the 2026 American Academy of Neurology Annual Meeting

AAN_Phase_2b_Presentation.pdf
Download Document
Kallyope logo
Kallyope Inc. | 430 East 29th Street, 10th Floor | New York, NY 10016
LinkedIn